Citation: Fe. Fox et al., PHOTOACTIVATED HYPERICIN IS AN ANTIPROLIFERATIVE AGENT THAT INDUCES AHIGH-RATE OF APOPTOTIC DEATH OF NORMAL, TRANSFORMED, AND MALIGNANT T-LYMPHOCYTES - IMPLICATIONS FOR THE TREATMENT OF CUTANEOUS LYMPHOPROLIFERATIVE AND INFLAMMATORY DISORDERS, Journal of investigative dermatology, 111(2), 1998, pp. 327-332
Authors:
ROOK AH
YOO EK
WOOD GS
ELENITSAS R
FOX FE
NIU Z
SHERMAN ML
KAO D
LESSIN SR
VONDERHEID EC
Citation: Ah. Rook et al., INTERLEUKIN-12 IS SAFE AND EFFECTIVE THERAPY FOR CUTANEOUS T-CELL LYMPHOMA, Journal of investigative dermatology, 110(4), 1998, pp. 679-679
Citation: Fe. Fox et al., PHOTOACTIVATED HYPERICIN INHIBITS PROLIFERATION AND INDUCES A HIGH-RATE OF APOPTOTIC DEATH OF NORMAL AND MALIGNANT T-LYMPHOCYTES FROM PATIENTS WITH CTCL, Journal of investigative dermatology, 110(4), 1998, pp. 693-693
Authors:
TORII H
HOSOI J
BEISSERT S
XU S
FOX FE
ASAHINA A
TAKASHIMA A
ROOK AH
GRANSTEIN RD
Citation: H. Torii et al., REGULATION OF CYTOKINE EXPRESSION IN MACROPHAGES AND THE LANGERHANS CELL-LIKE LINE XS52 BY CALCITONIN-GENE-RELATED PEPTIDE, Journal of leukocyte biology, 61(2), 1997, pp. 216-223
Citation: Fe. Fox et al., THE IL-12 SIGNAL-TRANSDUCTION PATHWAY IS DEFECTIVE IN MALIGNANT T-CELLS IN SEZARY-SYNDROME, Journal of investigative dermatology, 109(3), 1997, pp. 486-486
Citation: Ah. Rook et Fe. Fox, THE IMMUNOPATHOGENESIS OF CUTANEOUS T-CELL LYMPHOMA - THE CASE FOR BIOLOGICAL RESPONSE MODIFICATION, Journal of investigative dermatology, 109(3), 1997, pp. 490-490
Citation: Fe. Fox et al., CYTOKINE REGULATION OF THE GROWTH OF CLONAL MALIGNANT T-CELLS FROM PATIENTS WITH SEZARY-SYNDROME, Journal of investigative dermatology, 108(4), 1997, pp. 86-86
Authors:
FOX FE
KUBIN M
CASSIN M
NIU ZT
HOSOI J
TORII H
GRANSTEIN RD
TRINCHIERI G
ROOK AH
Citation: Fe. Fox et al., CALCITONIN-GENE-RELATED PEPTIDE INHIBITS PROLIFERATION AND ANTIGEN PRESENTATION BY HUMAN PERIPHERAL-BLOOD MONONUCLEAR-CELLS - EFFECTS ON B7, INTERLEUKIN-10, AND INTERLEUKIN-12, Journal of investigative dermatology, 108(1), 1997, pp. 43-48
Authors:
ROOK AH
GOTTLIEB SL
WOLFE JT
VOWELS BR
SOOD SS
NIU Z
LESSIN SR
FOX FE
Citation: Ah. Rook et al., PATHOGENESIS OF CUTANEOUS T-CELL LYMPHOMA - IMPLICATIONS FOR THE USE OF RECOMBINANT CYTOKINES AND PHOTOPHERESIS, Clinical and experimental immunology, 107, 1997, pp. 16-20
Authors:
GOTTLIEB SL
WOLFE JT
FOX FE
DENARDO BJ
MACEY WH
BROMLEY PG
LESSIN SR
ROOK AH
Citation: Sl. Gottlieb et al., TREATMENT OF CUTANEOUS T-CELL LYMPHOMA WITH EXTRACORPOREAL PHOTOPHERESIS MONOTHERAPY AND IN COMBINATION WITH RECOMBINANT INTERFERON-ALFA - A 10-YEAR EXPERIENCE AT A SINGLE INSTITUTION, Journal of the American Academy of Dermatology, 35(6), 1996, pp. 946-957
Citation: Fe. Fox et al., IL-15 AUGMENTS CELL-MEDIATED CYTOTOXICITY AND T-HELPER TYPE-I (TH1) CYTOKINE PRODUCTION BY PBMC FROM PATIENTS WITH SEZARY-SYNDROME, Journal of investigative dermatology, 106(4), 1996, pp. 784-784
Authors:
FOX FE
KUBIN M
CASSIN M
NIU Z
HOSOI J
TORJI H
GRANSTEIN RD
TRINCHIERI G
ROOK AH
Citation: Fe. Fox et al., CALCITONIN-GENE-RELATED PEPTIDE (CGRP) SUPPRESSES PROLIFERATION AND ANTIGEN PRESENTATION BY HUMAN PBMC - EFFECTS ON B7, INTERLEUKIN-10 AND INTERLEUKIN-12, Journal of investigative dermatology, 106(4), 1996, pp. 785-785
Authors:
CAPOCASALE RJ
LAMB RJ
VONDERHEID EC
FOX FE
ROOK AH
NOWELL PC
MOOREN JS
Citation: Rj. Capocasale et al., REDUCED SURFACE EXPRESSION OF TRANSFORMING GROWTH-FACTOR-BETA RECEPTOR-TYPE-II IN MITOGEN-ACTIVATED T-CELLS FROM SEZARY PATIENTS, Proceedings of the National Academy of Sciences of the United Statesof America, 92(12), 1995, pp. 5501-5505
Authors:
FOX FE
CASSIN M
GOTTLIEB S
FAKHARZADEH SS
KUBIN M
TRINCHIERI G
COOPER K
ROOK AH
Citation: Fe. Fox et al., RETINOIDS SYNERGIZE WITH IL-2 TO INCREASE INTERFERON-GAMMA (IFN-GAMMA) PRODUCTION BY PERIPHERAL-BLOOD MONONUCLEAR-CELLS VIA INDUCTION OF IL-12, Journal of investigative dermatology, 104(4), 1995, pp. 594-594
Authors:
WOLFE J
GOTTLIEB SL
FOX FE
DENARDO B
MACEY W
BROMLEY P
LESSIN SR
ROOK AH
Citation: J. Wolfe et al., TREATMENT OF CUTANEOUS T-CELL LYMPHOMA (CTCL) WITH EXTRACORPOREAL PHOTOCHEMOTHERAPY (ECP) AT THE UNIVERSITY-OF-PENNSYLVANIA, Journal of investigative dermatology, 104(4), 1995, pp. 662-662
Citation: Rj. Capocasale et al., FLOW CYTOMETRIC DETECTION OF INTRACELLULAR AND SURFACE TGF-BETA RECEPTOR TYPE-II IN HUMAN T-CELLS, The FASEB journal, 8(4), 1994, pp. 10000226-10000226
Citation: Fe. Fox et al., INHIBITION OF INTERLEUKIN-2 PRODUCTION AND ALTERATION OF INTERLEUKIN-2 MESSENGER-RNA PROCESSING BY HUMAN T-T CELL HYBRIDOMA-DERIVED SUPPRESSOR FACTORS, Hybridoma, 13(5), 1994, pp. 343-352
Authors:
NOWELL PC
MOORE JS
FOX FE
CAPOCASALE RJ
KANT JA
BESA EC
Citation: Pc. Nowell et al., RICHTERS-SYNDROME ASSOCIATED WITH LOSS OF RESPONSE TO TRANSFORMING GROWTH-FACTOR-BETA, Leukemia research, 18(2), 1994, pp. 85-89
Authors:
RODECK U
BOSSLER A
GRAEVEN U
FOX FE
NOWELL PC
KNABBE C
KARI C
Citation: U. Rodeck et al., TRANSFORMING GROWTH-FACTOR-BETA PRODUCTION AND RESPONSIVENESS IN NORMAL HUMAN MELANOCYTES AND MELANOMA-CELLS, Cancer research, 54(2), 1994, pp. 575-581
Authors:
SUZUKI R
FOX FE
SUZUKI S
OLESZAK EL
KUNICKA JE
PLATSOUCAS CD
Citation: R. Suzuki et al., PURIFICATION AND CHARACTERIZATION OF A HUMAN T-T-CELL HYBRIDOMA-DERIVED SUPPRESSOR FACTOR, The Journal of immunology, 150(8), 1993, pp. 131-131
Authors:
FOX FE
FORD HC
DOUGLAS R
CHERIAN S
NOWELL PC
Citation: Fe. Fox et al., EVIDENCE THAT TGF-BETA CAN INHIBIT HUMAN T-LYMPHOCYTE PROLIFERATION THROUGH PARACRINE AND AUTOCRINE MECHANISMS, Cellular immunology, 150(1), 1993, pp. 45-58